MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
NCT05333367 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-11-21
Summary
The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.
Conditions
- Cutaneous T-Cell Lymphoma
- Graft Vs Host Disease
- Graft Rejection
Interventions
- OTHER
-
Samples collection
Sampling of 2 samples on the extracorporeal photochemotherapy circuit, before and after sensitization with 8-MOP and UVA irradiation (without additional puncture)
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-15
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- France
Study Locations
More Related Trials
-
Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
NCT05923177 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
NCT06916637 ·Status: RECRUITING
-
HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer
NCT03827317 ·Status: RECRUITING ·Phase: NA
-
99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
NCT05622240 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
NCT05535621 ·Status: RECRUITING
-
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301 ·Status: WITHDRAWN ·Phase: PHASE2
-
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565 ·Status: RECRUITING ·Phase: NA
-
SMC Radiation Oncology Breast Cancer Cohort Study
NCT05775757 ·Status: RECRUITING
-
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
NCT00922961 ·Status: COMPLETED ·Phase: NA
-
RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer
NCT03000764 ·Status: COMPLETED ·Phase: NA
-
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
NCT05982626 ·Status: RECRUITING ·Phase: NA
-
Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3
NCT05376644 ·Status: COMPLETED ·Phase: NA
-
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NCT04925856 ·Status: RECRUITING ·Phase: NA
-
Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions
NCT01004666 ·Status: UNKNOWN
-
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
NCT01276899 ·Status: COMPLETED
-
Breast Cancer Molecular Analysis Protocol
NCT01855503 ·Status: COMPLETED
-
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
NCT01653964 ·Status: COMPLETED ·Phase: NA
-
HER2-PET Imaging in HER2-low Breast Cancers
NCT06732336 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
NCT04674722 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
NCT06321666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Contrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196 ·Status: ACTIVE_NOT_RECRUITING
-
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
NCT05692661 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
MR Characterisation/Localisation of Breast Cancer
NCT01567137 ·Status: COMPLETED